Biologics Contract Manufacturing Market, Global Outlook and Forecast 2022-2028

May 2022 | 61 pages | ID: B1CD29D237C3EN
Market Monitor Global

Abstracts

Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.

This report contains market size and forecasts of Biologics Contract Manufacturing in Global, including the following market information:

Global Biologics Contract Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biologics Contract Manufacturing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biologics Contract Manufacturing include Lonza Group, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim and Recipharm Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics Contract Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biologics Contract Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biologics Contract Manufacturing Market Segment Percentages, by Type, 2021 (%)

• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Molecular Therapy
• Others

Global Biologics Contract Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biologics Contract Manufacturing Market Segment Percentages, by Application, 2021 (%)

• Medical Company
• Hospital

Global Biologics Contract Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biologics Contract Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biologics Contract Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biologics Contract Manufacturing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Lonza Group
• Samsung Biologics Co., Ltd.
• Thermo Fisher Scientific, Inc.
• Cambrex Corporation
• Siegfried Holding AG
• Fujifilm Holding Corporation
• AbbVie, Inc.
• Boehringer Ingelheim
• Recipharm Pharmaceuticals
• WuXi Biologics
• Catalent, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Biologics Contract Manufacturing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Biologics Contract Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOLOGICS CONTRACT MANUFACTURING OVERALL MARKET SIZE

2.1 Global Biologics Contract Manufacturing Market Size: 2021 VS 2028
2.2 Global Biologics Contract Manufacturing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Biologics Contract Manufacturing Players in Global Market
3.2 Top Global Biologics Contract Manufacturing Companies Ranked by Revenue
3.3 Global Biologics Contract Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Biologics Contract Manufacturing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biologics Contract Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biologics Contract Manufacturing Players in Global Market
  3.6.1 List of Global Tier 1 Biologics Contract Manufacturing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Biologics Contract Manufacturing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Biologics Contract Manufacturing Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibodies
  4.1.3 Recombinant Proteins
  4.1.4 Vaccines
  4.1.5 Molecular Therapy
  4.1.6 Others
4.2 By Type - Global Biologics Contract Manufacturing Revenue & Forecasts
  4.2.1 By Type - Global Biologics Contract Manufacturing Revenue, 2017-2022
  4.2.2 By Type - Global Biologics Contract Manufacturing Revenue, 2023-2028
  4.2.3 By Type - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Biologics Contract Manufacturing Market Size, 2021 & 2028
  5.1.2 Medical Company
  5.1.3 Hospital
5.2 By Application - Global Biologics Contract Manufacturing Revenue & Forecasts
  5.2.1 By Application - Global Biologics Contract Manufacturing Revenue, 2017-2022
  5.2.2 By Application - Global Biologics Contract Manufacturing Revenue, 2023-2028
  5.2.3 By Application - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Biologics Contract Manufacturing Market Size, 2021 & 2028
6.2 By Region - Global Biologics Contract Manufacturing Revenue & Forecasts
  6.2.1 By Region - Global Biologics Contract Manufacturing Revenue, 2017-2022
  6.2.2 By Region - Global Biologics Contract Manufacturing Revenue, 2023-2028
  6.2.3 By Region - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Biologics Contract Manufacturing Revenue, 2017-2028
  6.3.2 US Biologics Contract Manufacturing Market Size, 2017-2028
  6.3.3 Canada Biologics Contract Manufacturing Market Size, 2017-2028
  6.3.4 Mexico Biologics Contract Manufacturing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Biologics Contract Manufacturing Revenue, 2017-2028
  6.4.2 Germany Biologics Contract Manufacturing Market Size, 2017-2028
  6.4.3 France Biologics Contract Manufacturing Market Size, 2017-2028
  6.4.4 U.K. Biologics Contract Manufacturing Market Size, 2017-2028
  6.4.5 Italy Biologics Contract Manufacturing Market Size, 2017-2028
  6.4.6 Russia Biologics Contract Manufacturing Market Size, 2017-2028
  6.4.7 Nordic Countries Biologics Contract Manufacturing Market Size, 2017-2028
  6.4.8 Benelux Biologics Contract Manufacturing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Biologics Contract Manufacturing Revenue, 2017-2028
  6.5.2 China Biologics Contract Manufacturing Market Size, 2017-2028
  6.5.3 Japan Biologics Contract Manufacturing Market Size, 2017-2028
  6.5.4 South Korea Biologics Contract Manufacturing Market Size, 2017-2028
  6.5.5 Southeast Asia Biologics Contract Manufacturing Market Size, 2017-2028
  6.5.6 India Biologics Contract Manufacturing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Biologics Contract Manufacturing Revenue, 2017-2028
  6.6.2 Brazil Biologics Contract Manufacturing Market Size, 2017-2028
  6.6.3 Argentina Biologics Contract Manufacturing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Biologics Contract Manufacturing Revenue, 2017-2028
  6.7.2 Turkey Biologics Contract Manufacturing Market Size, 2017-2028
  6.7.3 Israel Biologics Contract Manufacturing Market Size, 2017-2028
  6.7.4 Saudi Arabia Biologics Contract Manufacturing Market Size, 2017-2028
  6.7.5 UAE Biologics Contract Manufacturing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Lonza Group
  7.1.1 Lonza Group Corporate Summary
  7.1.2 Lonza Group Business Overview
  7.1.3 Lonza Group Biologics Contract Manufacturing Major Product Offerings
  7.1.4 Lonza Group Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.1.5 Lonza Group Key News
7.2 Samsung Biologics Co., Ltd.
  7.2.1 Samsung Biologics Co., Ltd. Corporate Summary
  7.2.2 Samsung Biologics Co., Ltd. Business Overview
  7.2.3 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Major Product Offerings
  7.2.4 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.2.5 Samsung Biologics Co., Ltd. Key News
7.3 Thermo Fisher Scientific, Inc.
  7.3.1 Thermo Fisher Scientific, Inc. Corporate Summary
  7.3.2 Thermo Fisher Scientific, Inc. Business Overview
  7.3.3 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Major Product Offerings
  7.3.4 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific, Inc. Key News
7.4 Cambrex Corporation
  7.4.1 Cambrex Corporation Corporate Summary
  7.4.2 Cambrex Corporation Business Overview
  7.4.3 Cambrex Corporation Biologics Contract Manufacturing Major Product Offerings
  7.4.4 Cambrex Corporation Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.4.5 Cambrex Corporation Key News
7.5 Siegfried Holding AG
  7.5.1 Siegfried Holding AG Corporate Summary
  7.5.2 Siegfried Holding AG Business Overview
  7.5.3 Siegfried Holding AG Biologics Contract Manufacturing Major Product Offerings
  7.5.4 Siegfried Holding AG Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.5.5 Siegfried Holding AG Key News
7.6 Fujifilm Holding Corporation
  7.6.1 Fujifilm Holding Corporation Corporate Summary
  7.6.2 Fujifilm Holding Corporation Business Overview
  7.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Major Product Offerings
  7.6.4 Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.6.5 Fujifilm Holding Corporation Key News
7.7 AbbVie, Inc.
  7.7.1 AbbVie, Inc. Corporate Summary
  7.7.2 AbbVie, Inc. Business Overview
  7.7.3 AbbVie, Inc. Biologics Contract Manufacturing Major Product Offerings
  7.7.4 AbbVie, Inc. Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.7.5 AbbVie, Inc. Key News
7.8 Boehringer Ingelheim
  7.8.1 Boehringer Ingelheim Corporate Summary
  7.8.2 Boehringer Ingelheim Business Overview
  7.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Major Product Offerings
  7.8.4 Boehringer Ingelheim Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.8.5 Boehringer Ingelheim Key News
7.9 Recipharm Pharmaceuticals
  7.9.1 Recipharm Pharmaceuticals Corporate Summary
  7.9.2 Recipharm Pharmaceuticals Business Overview
  7.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Major Product Offerings
  7.9.4 Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.9.5 Recipharm Pharmaceuticals Key News
7.10 WuXi Biologics
  7.10.1 WuXi Biologics Corporate Summary
  7.10.2 WuXi Biologics Business Overview
  7.10.3 WuXi Biologics Biologics Contract Manufacturing Major Product Offerings
  7.10.4 WuXi Biologics Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.10.5 WuXi Biologics Key News
7.11 Catalent, Inc.
  7.11.1 Catalent, Inc. Corporate Summary
  7.11.2 Catalent, Inc. Business Overview
  7.11.3 Catalent, Inc. Biologics Contract Manufacturing Major Product Offerings
  7.11.4 Catalent, Inc. Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
  7.11.5 Catalent, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Biologics Contract Manufacturing Market Opportunities & Trends in Global Market
Table 2. Biologics Contract Manufacturing Market Drivers in Global Market
Table 3. Biologics Contract Manufacturing Market Restraints in Global Market
Table 4. Key Players of Biologics Contract Manufacturing in Global Market
Table 5. Top Biologics Contract Manufacturing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biologics Contract Manufacturing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biologics Contract Manufacturing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biologics Contract Manufacturing Product Type
Table 9. List of Global Tier 1 Biologics Contract Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics Contract Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biologics Contract Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biologics Contract Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biologics Contract Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biologics Contract Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biologics Contract Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biologics Contract Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biologics Contract Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biologics Contract Manufacturing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biologics Contract Manufacturing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biologics Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biologics Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biologics Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biologics Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biologics Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 30. Lonza Group Corporate Summary
Table 31. Lonza Group Biologics Contract Manufacturing Product Offerings
Table 32. Lonza Group Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 33. Samsung Biologics Co., Ltd. Corporate Summary
Table 34. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product Offerings
Table 35. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific, Inc. Corporate Summary
Table 37. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product Offerings
Table 38. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 39. Cambrex Corporation Corporate Summary
Table 40. Cambrex Corporation Biologics Contract Manufacturing Product Offerings
Table 41. Cambrex Corporation Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 42. Siegfried Holding AG Corporate Summary
Table 43. Siegfried Holding AG Biologics Contract Manufacturing Product Offerings
Table 44. Siegfried Holding AG Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 45. Fujifilm Holding Corporation Corporate Summary
Table 46. Fujifilm Holding Corporation Biologics Contract Manufacturing Product Offerings
Table 47. Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie, Inc. Corporate Summary
Table 49. AbbVie, Inc. Biologics Contract Manufacturing Product Offerings
Table 50. AbbVie, Inc. Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 51. Boehringer Ingelheim Corporate Summary
Table 52. Boehringer Ingelheim Biologics Contract Manufacturing Product Offerings
Table 53. Boehringer Ingelheim Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 54. Recipharm Pharmaceuticals Corporate Summary
Table 55. Recipharm Pharmaceuticals Biologics Contract Manufacturing Product Offerings
Table 56. Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 57. WuXi Biologics Corporate Summary
Table 58. WuXi Biologics Biologics Contract Manufacturing Product Offerings
Table 59. WuXi Biologics Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 60. Catalent, Inc. Corporate Summary
Table 61. Catalent, Inc. Biologics Contract Manufacturing Product Offerings
Table 62. Catalent, Inc. Biologics Contract Manufacturing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Biologics Contract Manufacturing Segment by Type in 2021
Figure 2. Biologics Contract Manufacturing Segment by Application in 2021
Figure 3. Global Biologics Contract Manufacturing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biologics Contract Manufacturing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biologics Contract Manufacturing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biologics Contract Manufacturing Revenue in 2021
Figure 8. By Type - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biologics Contract Manufacturing Revenue Market Share, 2017-2028
Figure 12. US Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biologics Contract Manufacturing Revenue Market Share, 2017-2028
Figure 16. Germany Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 17. France Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biologics Contract Manufacturing Revenue Market Share, 2017-2028
Figure 24. China Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 28. India Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biologics Contract Manufacturing Revenue Market Share, 2017-2028
Figure 30. Brazil Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biologics Contract Manufacturing Revenue Market Share, 2017-2028
Figure 33. Turkey Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biologics Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 37. Lonza Group Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cambrex Corporation Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Siegfried Holding AG Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie, Inc. Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Boehringer Ingelheim Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. WuXi Biologics Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Catalent, Inc. Biologics Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)